BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10077374)

  • 1. Tolerance to ACE inhibitors after cardiac surgery.
    Manché A; Galea J; Busuttil W
    Eur J Cardiothorac Surg; 1999 Jan; 15(1):55-60. PubMed ID: 10077374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Slovak Investigator Group.
    Vítovec J; Spinar J
    Eur J Heart Fail; 2000 Sep; 2(3):299-304. PubMed ID: 10938492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative haemodynamic responses to the first dose of short- and long-acting ACE inhibitors in patients with congestive heart failure.
    Anthopoulos L; Apostolou T; Bonoris P; Foussas S; Lefkos N; Zombolos S
    Curr Med Res Opin; 2001; 17(4):290-7. PubMed ID: 11922403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
    Sami MH
    Can J Cardiol; 1994 Nov; 10 Suppl D():13D-16D. PubMed ID: 7954033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ; Lees KR; Reid JL
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD).
    Knight EL; Glynn RJ; McIntyre KM; Mogun H; Avorn J
    Am Heart J; 1999 Nov; 138(5 Pt 1):849-55. PubMed ID: 10539815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure: a Malaysian experience.
    Navookarasu NT; Rahman AR; Abdullah I
    Int J Clin Pract; 1999; 53(1):25-30. PubMed ID: 10344062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure response to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Reid JL; MacFadyen RJ; Squire IB; Lees KR
    Am J Cardiol; 1993 Jun; 71(17):57E-60E. PubMed ID: 8392282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery.
    Chiba K; Moriyama S; Ishigai Y; Fukuzawa A; Irie K; Shibano T
    Br J Pharmacol; 1994 Jul; 112(3):837-42. PubMed ID: 7921610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the first dose hypotensive effects of captopril and perindopril in patients with heart failure.
    Cardiovasc Drugs Ther; 2001 Nov; 15(6):501-6. PubMed ID: 11916359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function.
    Bertrand ME; Remme WJ; Fox KM; Ferrari R; Simoons ML;
    Int J Cardiol; 2007 Sep; 121(1):57-61. PubMed ID: 17270296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Squire IB; MacFayden RJ; Reid JL; Devlin A; Lees KR
    J Cardiovasc Pharmacol; 1996 May; 27(5):657-66. PubMed ID: 8859935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specialist nurse supervised in-hospital titration to target dose ACE inhibitor--is it safe and feasible in a community heart failure population?
    Ryder M; Travers B; Timmons L; Ledwidge M; McDonald K
    Eur J Cardiovasc Nurs; 2003 Sep; 2(3):183-8. PubMed ID: 14622625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of perindopril with enalapril in rats with dilated cardiomyopathy.
    Watanabe K; Saito Y; Ma M; Wahed M; Abe Y; Hirabayashi K; Narasimman G; Wen J; Suresh P; Ali F; Shirai K; Soga M; Nagai Y; Nakazawa M; Hasegawa G; Naito M; Tachikawa H; Kodama M; Aizawa Y; Yamaguchi K; Takahashi T
    J Cardiovasc Pharmacol; 2003 Dec; 42 Suppl 1():S105-9. PubMed ID: 14871039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):964-71. PubMed ID: 15803314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE inhibitors in heart failure--switching from enalapril to perindopril.
    Masuell M; Brusca G; Pardo A; Piñeiro D; Checkerdhemian S; Forcada P
    Curr Med Res Opin; 2002; 18(5):296-302. PubMed ID: 12240792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perindopril: in congestive heart failure.
    Simpson D; Noble S; Goa KL
    Drugs; 2002; 62(9):1367-77; discussion 1378-9. PubMed ID: 12076191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.